Expression of Concern: Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomized Study

No AccessJournal of UrologyExpression of Concern10 Jan 2023Expression of Concern: Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomized Studyis a expression-of-concern ofComparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomized Study Mohammad Reza Safarinejad, Seyyed Yousof Hosseini, and Ali Asgar Kolahi Mohammad Reza SafarinejadMohammad Reza Safarinejad *Correspondence: P.O. Box 19395-1849, Tehran, Iran telephone: 0098 21 22454499; FAX: 0098 21 22456845; E-mail Address: [email protected] More articles by this author , Seyyed Yousof HosseiniSeyyed Yousof Hosseini More articles by this author , and Ali Asgar KolahiAli Asgar Kolahi More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003118AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Expression of Concern: Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomized Study." The Journal of Urology, Publish Ahead of Print, pp. Study received Human Ethics Committee approval. From the Urology and Nephrology Research Center, and Department of Health and Community Medicine, Faculty of Medicine, Shaheed Beheshti University of Medical Sciences, Tehran, Iran© 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology15 Aug 2007Comparison of Vitamin E and Propionyl-L-Carnitine, Separately or in Combination, in Patients With Early Chronic Peyronie’s Disease: A Double-Blind, Placebo Controlled, Randomized Study Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Mohammad Reza Safarinejad *Correspondence: P.O. Box 19395-1849, Tehran, Iran telephone: 0098 21 22454499; FAX: 0098 21 22456845; E-mail Address: [email protected] More articles by this author Seyyed Yousof Hosseini More articles by this author Ali Asgar Kolahi More articles by this author Expand All Study received Human Ethics Committee approval. Advertisement PDF downloadLoading ...